Which combination of therapies would address inflammation, itch, and infection in this case?

• A. Topicals, JAK inhibitors, IL-31 antibody
• B. Vaccination and antibiotics
• C. Radiation therapy
• D. Surgical excision

Answer: (A)

Managing an inflammatory itchy skin condition with infection requires a multi-pronged approach that tackles inflammation, itch, and infection at once. The combination of topical therapies, a JAK inhibitor, and an IL-31–targeting antibody does just that. Topicals help reduce local inflammation and can treat or prevent surface infection. A JAK inhibitor dampens the broader inflammatory signaling driving redness, swelling, and pain, which also helps lessen itch. An IL-31–blocking antibody directly interrupts a key itch signaling pathway, providing targeted relief from pruritus. Together, these components address the inflammatory process, the itch sensation, and the infectious component. Other options don’t cover all three: vaccination with antibiotics mainly targets infection and doesn’t address itch and inflammation; and radiation or surgical excision don’t treat the inflammatory itch-infection triad in this context.